US Patent Issued to NAVI BIO-THERAPEUTICS on March 25 for "Antibody specific to nectin cell adhesion molecule 4 and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,402, issued on March 25, was assigned to NAVI BIO-THERAPEUTICS INC. (Kaohsiung, Taiwan).

"Antibody specific to nectin cell adhesion molecule 4 and uses thereof" was invented by Bor-Yu Tsai (New Taipei, Taiwan), Shin-Tsung Huang (Taipei, Taiwan) and Wei-Ting Hsu (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a modified antibody, or antigen-binding fragment thereof, specific for nectin cell adhesion molecule 4 (nectin-4). The present disclosure also relates to a method of detecting or diagnosing whether a subject has, or is at risk of developing a tumor, or assessing a prognosis of a tumor and a pharm...